4//SEC Filing
BOYNTON ALTON L 4
Accession 0001104659-20-080808
CIK 0001072379other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 9:55 PM ET
Size
8.0 KB
Accession
0001104659-20-080808
Insider Transaction Report
Form 4
BOYNTON ALTON L
DirectorChief Executive Officer
Transactions
- Award
Options to purchase Common Stock, par value $0.001
2020-07-02+2,491,338→ 2,491,338 totalExercise: $0.21From: 2020-07-02Exp: 2030-07-02→ Common Stock, par value $0.001 (2,491,338 underlying) - Award
Options to purchase Common Stock, par value $0.001
2020-07-02+605,160→ 605,160 totalExercise: $0.25From: 2020-07-02Exp: 2030-07-02→ Common Stock, par value $0.001 (605,160 underlying)
Footnotes (2)
- [F1]These options were already approved and publicly reported in 2018. The exercise price was determined with reference to the pricing for unrelated investors at that time. However, the documents to implement and issue (grant) them have not been executed until now.
- [F2]These options were approved in January 2020. The exercise price was determined based upon the pricing in year-end financings with unrelated investors. However, these options have not been executed and implemented (granted) until now.
Documents
Issuer
NORTHWEST BIOTHERAPEUTICS INC
CIK 0001072379
Entity typeother
Related Parties
1- filerCIK 0001253935
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 9:55 PM ET
- Size
- 8.0 KB